Robert M Dewitty

Array ( [id] => 4158516 [patent_doc_number] => 06156786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => '2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome' [patent_app_type] => 1 [patent_app_number] => 9/185929 [patent_app_country] => US [patent_app_date] => 1998-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6542 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156786.pdf [firstpage_image] =>[orig_patent_app_number] => 185929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543045 [patent_doc_number] => 06372728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Formulation for treatment of osteoporosis' [patent_app_type] => B1 [patent_app_number] => 09/171950 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3581 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372728.pdf [firstpage_image] =>[orig_patent_app_number] => 09171950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045696 [patent_doc_number] => 05912259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone' [patent_app_type] => 1 [patent_app_number] => 9/171891 [patent_app_country] => US [patent_app_date] => 1998-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4752 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912259.pdf [firstpage_image] =>[orig_patent_app_number] => 171891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421210 [patent_doc_number] => 06177472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Regulation of alzheimer\'s disease proteins and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/179777 [patent_app_country] => US [patent_app_date] => 1998-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15009 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177472.pdf [firstpage_image] =>[orig_patent_app_number] => 179777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410496 [patent_doc_number] => 06228864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation' [patent_app_type] => 1 [patent_app_number] => 9/181071 [patent_app_country] => US [patent_app_date] => 1998-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9946 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228864.pdf [firstpage_image] =>[orig_patent_app_number] => 181071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089359 [patent_doc_number] => 06133254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Use of aspirochlorine or derivatives thereof as immunosuppressive agents' [patent_app_type] => 1 [patent_app_number] => 9/171848 [patent_app_country] => US [patent_app_date] => 1998-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3617 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133254.pdf [firstpage_image] =>[orig_patent_app_number] => 171848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4090535 [patent_doc_number] => 06133320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors' [patent_app_type] => 1 [patent_app_number] => 9/177978 [patent_app_country] => US [patent_app_date] => 1998-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4847 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133320.pdf [firstpage_image] =>[orig_patent_app_number] => 177978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103120 [patent_doc_number] => 06100237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis' [patent_app_type] => 1 [patent_app_number] => 9/172077 [patent_app_country] => US [patent_app_date] => 1998-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2321 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100237.pdf [firstpage_image] =>[orig_patent_app_number] => 172077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514757 [patent_doc_number] => 06420353 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Use of 7 -substituted steroid to treat neuropsychiatric, immune or endocrine disorders' [patent_app_type] => B1 [patent_app_number] => 09/168218 [patent_app_country] => US [patent_app_date] => 1998-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 11614 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420353.pdf [firstpage_image] =>[orig_patent_app_number] => 09168218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4104967 [patent_doc_number] => RE036606 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Synergistic pharmaceutical compositions' [patent_app_type] => 2 [patent_app_number] => 9/168317 [patent_app_country] => US [patent_app_date] => 1998-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 36 [patent_no_of_words] => 6454 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/036/RE036606.pdf [firstpage_image] =>[orig_patent_app_number] => 168317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133548 [patent_doc_number] => 06147112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Use of 2,5-dihydroxybenzenesulfonic derivatives for the normalization of endothelial function' [patent_app_type] => 1 [patent_app_number] => 9/155751 [patent_app_country] => US [patent_app_date] => 1998-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1283 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147112.pdf [firstpage_image] =>[orig_patent_app_number] => 155751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143619 [patent_doc_number] => 06030984 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Pyridone compounds useful in treating Alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 9/161853 [patent_app_country] => US [patent_app_date] => 1998-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10514 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 311 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030984.pdf [firstpage_image] =>[orig_patent_app_number] => 161853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1567152 [patent_doc_number] => 06376549 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Metforimin-containing compositions for the treatment of diabetes' [patent_app_type] => B1 [patent_app_number] => 09/156102 [patent_app_country] => US [patent_app_date] => 1998-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6246 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376549.pdf [firstpage_image] =>[orig_patent_app_number] => 09156102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409471 [patent_doc_number] => 06239178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Method of treating mammals' [patent_app_type] => 1 [patent_app_number] => 9/148443 [patent_app_country] => US [patent_app_date] => 1998-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3503 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239178.pdf [firstpage_image] =>[orig_patent_app_number] => 148443 [rel_patent_id] =>[rel_patent_doc_number] =>)